医学
奥拉帕尼
肿瘤科
贝伐单抗
内科学
荟萃分析
危险系数
人口
卵巢癌
卡铂
无进展生存期
癌症
置信区间
化疗
聚ADP核糖聚合酶
生物
基因
环境卫生
聚合酶
顺铂
生物化学
作者
Nicoletta Staropoli,Domenico Ciliberto,Francesco Luciano,Cristina Napoli,Martina Costa,Giacomo Rossini,Mariamena Arbitrio,Caterina Labanca,Caterina Riillo,Teresa Del Giudice,Antonella Crispino,Angela Salvino,Antonio Galvano,Antonio Russo,Pierfrancesco Tassone,Pierosandro Tagliaferri
标识
DOI:10.1016/j.critrevonc.2023.104229
摘要
Carboplatin is still the cornerstone of the first-line treatment in advanced Epithelial Ovarian Cancer (aEOC) management and the clinical response to platinum-derived agents remains the major predictor of long-term outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI